Review of statistical methods for analysing healthcare resources and costs

Abstract

We review statistical methods for analysing healthcare resource use and costs, their ability to address skewness, excess zeros, multimodality and heavy right tails, and their ease for general use. We aim to provide guidance on analysing resource use and costs focusing on randomised trials, although methods often have wider applicability. Twelve broad categories of methods were identified: (I) methods based on the normal distribution, (II) methods following transformation of data, (III) single-distribution generalized linear models (GLMs), (IV) parametric models based on skewed distributions outside the GLM family, (V) models based on mixtures of parametric distributions, (VI) two (or multi)-part and Tobit models, (VII) survival methods, (VIII) non-parametric methods, (IX) methods based on truncation or trimming of data, (X) data components models, (XI) methods based on averaging across models, and (XII) Markov chain methods. Based on this review, our recommendations are that, first, simple methods are preferred in large samples where the near-normality of sample means is assured. Second, in somewhat smaller samples, relatively simple methods, able to deal with one or two of above data characteristics, may be preferable but checking sensitivity to assumptions is necessary. Finally, some more complex methods hold promise, but are relatively untried; their implementation requires substantial expertise and they are not currently recommended for wider applied work.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 98

1. 1.

   Abrevaya J. Computing marginal effects in the Box-Cox Model. Econometric Reviews. 2002;21(3):383-393.

   Not in our library

2. 2.

   Ai C, Norton EC. Standard errors for the retransformation problem with heteroscedasticity. Journal of Health and Economics. 2000;19(5):697-718.

   Not in our library10.1016/s0167-6296(00)00046-1

3. 3.

   Ai C, Norton EC. A semiparametric derivative estimator in log transformation models. Econometrics Journal. 2008;11:538-553.

   Not in our library

4. 4.

   Arrow KJ. Uncertainty and the evaluation of public investment decisions. The American Economic Review. 1970;60(3):364-378.

   Not in our library

5. 5.

   Atienza N, Garcia-Heras J, Munoz-Pichardo JM, Villa R. An application of mixture distributions in modelization of length of hospital stay. Statistics in Medicine. 2008;27(9):1403-1420.

   Not in our library10.1002/sim.3029

6. 6.

   Austin PC, Ghali WA, Tu JV. A comparison of several regression models for analysing cost of CABG surgery. Statistics in Medicine. 2003;22(17):2799-2815.

   Not in our library10.1002/sim.1442

7. 7.

   Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Statistics in Medicine. 2000;19(23):3219-3236.

   Not in our library10.1002/1097-0258(20001215)19:23<3219::aid-sim623>3.0.co;2-p

8. 8.

   Basu A. Extended generalised linear models: simultaneous estimation of flexible link and variance functions. The Stata Journal. 2005;5(4):501-516.

   Not in our library

9. 9.

   Basu A, Arondekar BV, Rathouz PJ. Scale of interest versus scale of estimation: Comparing alternative estimators for the incremental costs of a comorbidity. Health Econonics. 2006;15:1091-1107.

   Not in our library10.1002/hec.1099

10. 10.

    Basu A, Manning WG. A test for proportional hazards assumption within the exponential conditional mean framework. Health Services and Outcomes Research Methodology. 2006;6:81-100.

    Not in our library

11. 11.

    Basu A, Manning WG. Issues for the next generation of health care cost analyses. Medical Care. 2009;47(7):S109-S114.

    Not in our library10.1097/mlr.0b013e31819c94a1

12. 12.

    Basu A, Manning WG, Mullahy J. Comparing alternative models: log vs cox proportional hazard? Health Economics. 2004;13(8):749-765.

    Not in our library10.1002/hec.852

13. 13.

    Basu A, Rathouz PJ. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics. 2005;6(1):93-109.

    Not in our library10.1093/biostatistics/kxh020

14. 14.

    Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. Journal of Health Economics. 1999;18(2):153-171.

    Not in our library10.1016/s0167-6296(98)00032-0

15. 15.

    Blough DK, Ramsey SD. Using generalised linear models to assess medical care costs. Health Services and Outcomes Research Methodology. 2000;1:185-202.

    Not in our library

16. 16.

    Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. Journal of Health Services Research and Policy. 1998;3(4):233-245.

    Not in our library10.1177/135581969800300410

17. 17.

    Briggs A, Nixon R, Dixon S, Thompson S. Parametric modelling of cost data: some simulation evidence. Health Economics. 2005;14(4):421-428.

    Not in our library10.1002/hec.941

18. 18.

    Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. Journal of Health Economics. 2004;23(3):525-542.

    Not in our library10.1016/j.jhealeco.2003.10.005

19. 19.

    Cameron AC, Johansson P. Count data regression using series expansions: with applications. Journal of Applied Econometrics. 1997;12(3):203-223.

    Not in our library

20. 20.

    Cameron AC, Johansson P. Bivariate count data regression using series expansions: with applications. Department of Economics Discussion Paper [15]. 1998.

    Not in our library

21. 21.

    Cameron AC, Li T, Trivedi PK, Zimmer DM. Modelling the differences in counted outcomes using bivariate copula models with application to mismeasured counts. Econometrics Journal. 2004;7(2):566-584.

    Not in our library

22. 22.

    Cameron AC, Trivedi PK. Econometric models based on count data: comparisons and applications of some estimators and tests. Journal of Applied Econometrics. 1986;1(1):29-53.

    Not in our library

23. 23.

    Cameron AC, Trivedi PK. Regression Analysis of Count Data. 1998.

    Not in our library

24. 24.

    Cameron AC, Trivedi PK. Microeconometrics Using Stata. 2009.

    Not in our library

25. 25.

    Cantoni E, Ronchetti E. Robust inference for generalized linear models. Journal of the American Statistical Association. 2001;96(455):1022-1030.

    Not in our library

26. 26.

    Cantoni E, Ronchetti E. A robust approach for skewed and heavy-tailed outcomes in the analysis of health care expenditures. Journal of Health Economics. 2006;25(2):198-213.

    Not in our library10.1016/j.jhealeco.2005.04.010

27. 27.

    Chen YH, Zhou XH. Interval estimates for the ratio and difference of two lognormal means. Statistics in Medicine. 2006;25:4099-4113.

    Not in our library10.1002/sim.2504

28. 28.

    Chib S, Winkelmann R. Markov chain Monte Carlo analysis of correlated count data. Journal of Business and Economic Statistics. 2001;19(4):428-435.

    Not in our library

29. 29.

    Conigliani C, Tancredi A. Semi-parametric modelling for costs of health care technologies. Statistics in Medicine. 2005;24(20):3171-3184.

    Not in our library10.1002/sim.2012

30. 30.

    Conigliani C, Tancredi A. Comparing parametric and semi-parametric approaches for Bayesian cost-effectiveness analyses. Working Paper del Dipartimento di Economia [64]. 2006.

    Not in our library

31. 31.

    Conigliani C, Tancredi A. A Bayesian model averaging approach for cost-effectiveness analyses. Health Economics. 2009;18(7):807-821.

    Not in our library10.1002/hec.1404

32. 32.

    Cooper NJ, Lambert PC, Abrams KR, Sutton AJ. Predicting costs over time using Bayesian Markov chain Monte Carlo methods: an application to early inflammatory polyarthritis. Health Economics. 2007;16(1):37-56.

    Not in our library10.1002/hec.1141

33. 33.

    Cooper NJ, Sutton AJ, Mugford M, Abrams KR. Use of Bayesian Markov chain Monte Carlo methods to model cost-of-illness data. Medical Decision Making. 2003;23(1):38-53.

    Not in our library10.1177/0272989x02239653

34. 34.

    Deb P, Burgess JA. Quasi-experimental comparison of econometric models for health care expenditures. Department of Economics Working Papers [212]. 2003.

    Not in our library

35. 35.

    Deb P, Holmes AM. Estimates of use and costs of behavioural health care: a comparison of standard and finite mixture models. Health Economics. 2000;9(6):475-489.

    Not in our library10.1002/1099-1050(200009)9:6<475::aid-hec544>3.0.co;2-h

36. 36.

    Deb P, Trivedi PK. Demand for medical care by the elderly: a finite mixture approach. Journal of Applied Econometrics. 1997;12(3):313-336.

    Not in our library

37. 37.

    Deb P, Trivedi PK. The structure of demand for health care: latent class versus two-part models. Journal of Health Economics. 2002;21(4):601-625.

    Not in our library10.1016/s0167-6296(02)00008-5

38. 38.

    Dinh P, Zhou XH. Nonparametric statistical methods for cost-effectiveness analyses. Biometrics. 2006;62(2):576-588.

    Not in our library10.1111/j.1541-0420.2006.00509.x

39. 39.

    Dominici F, Cope L, Naiman DQ, Zeger SL. Smooth quantile ratio estimation. Biometrika. 2005;92(3):543-557.

    Not in our library

40. 40.

    Dominici F, Zeger SL. Smooth quantile ratio estimation with regression: estimating medical expenditures for smoking-attributable diseases. Biostatistics. 2005;6(4):505-519.

    Not in our library10.1093/biostatistics/kxi031

Cited by papers we hold 11

• Costs of multimorbidity: a systematic review and meta-analyses · 2022
  No notice
• The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial · 2021
  Corrected
• The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial · 2021
  Corrected
• Determinants of healthcare seeking and out-of-pocket expenditures in a “free” healthcare system: evidence from rural Malawi · 2020
  Not checked
• Comparison of statistical and machine learning models for healthcare cost data: a simulation study motivated by Oncology Care Model (OCM) data · 2020
  Not checked
• Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012–2013 Medical Expenditure Panel Survey · 2018
  Not checked
• CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children · 2016
  Not checked
• Health-related quality of life measured using the EQ-5D–5L: South Australian population norms · 2016
  No notice
• Statistical models for the analysis of skewed healthcare cost data: a simulation study · 2015
  No notice
• The Contribution of Social Networks to the Health and Self-Management of Patients with Long-Term Conditions: A Longitudinal Study · 2014
  No notice
• Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients · 2011
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.